In the Basic Pharmaceutical Sciences Department, studies are conducted using fundamental molecular biology techniques, including in vitro viability, cytotoxicity, and genotoxicity tests to determine the biological effects of nanomaterials, various experimental model applications in animal studies, histopathological evaluations of active substances' acute effects in vivo, gene expression studies, cell interactions, immunohistochemical techniques to detect biomolecules, interactions between cells and the extracellular matrix, the effects of cell surface oligosaccharides on cancer cell behavior, elucidation of programmed cell death mechanisms, and mesenchymal stem cell studies.

Current priority research areas include cellular technologies, recombinant protein and antibody production in mammalian cells, and developing biological materials with "biotechnological drug raw material" potential. Goals include identifying biological resources, obtaining beneficial products from these resources, determining their effects through in vivo and in vitro experimental models, and applying genomics and proteomics.